TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04747236

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romidepsin
Description: Romidepsin, 14 mg/m2 as an intravenous infusion over 4 hours on Days 8, 15, and 22 of a 35-day cycle

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Romidepsin
Description: Romidepsin, 14 mg/m2 as an intravenous infusion over 4 hours on Days 8, 15, and 22 of a 35-day cycle

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Belinostat
Description: Belinostat, 1000 mg/m2 as an intravenous infusion over 30 minutes on Days 1-5 every 21 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pralatrexate
Description: Pralatrexate, 30 mg/m2 as an intravenous infusion over a 3-5 minute push once weekly for 6 weeks of a 7 week treatment cycle.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: Gemcitabine, 1000 mg/m2 as an intravenous infusion over 30 minutes on Days 1, 8, and 15 of a 28 day cycle.
Study: NCT05570656

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: XSENS-Awinda
Description: The participant wears inertial sensors X-Sens that measure the kinematic data and the amplitude of joint movements during different movements (flexion and extension of the spine, walking, picking up an object on the ground, tying their shoelaces, getting up from a chair... ) Each movement will be repeated 3 times.~Participants will also have self-questionnaires to complete (BASDAI and BASFI).~The exams are carried out on one day.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: XSENS-Awinda
Description: The participant wears inertial sensors X-Sens that measure the kinematic data and the amplitude of joint movements during different movements (flexion and extension of the spine, walking, picking up an object on the ground, tying their shoelaces, getting up from a chair... ) Each movement will be repeated 3 times.~Participants will also have self-questionnaires to complete (BASDAI and BASFI).~The exams are carried out on one day.
Study: NCT04706312

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: stem cells
Description: hAMSCs injection via venous in the dorsum of hand
Study: NCT03978611

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relatlimab
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Specified dose on specified days
Study: NCT05130385

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography
Study: NCT06425250

Intervention type: OTHER
Intervention: Management, progression and risk factors for failure of BJI caused by Campylobacter spp.
Description: Description of demographic data (sex, age), comorbidities (ASA and Charlson scores), orthopedic and septic history, and surgical and medical management (antibiotic therapy)

Intervention type: OTHER
Intervention: Description of the evolution and risk factors for failure of osteoarticular infections caused by Campylobacter spp.
Description: Failure of treatment: defined according to a composite criterion bringing together~* persistence of the infection under treatment, and/or~* recurrence of the infection after stopping antibiotic therapy, and/or~* need for surgical revision for septic reasons more than 5 days after initial treatment, and/or~* superinfection, and/or~* definitive explantation of the material, and/or~* decision for suppressive antibiotic therapy, and/or~* amputation, and/or~* death linked to infection
Study: NCT06296992

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 12-week TEAM peer mentor program
Description: A 12-week peer-led behavioural intervention that supports increased physical activity. It will consist of 3 weekly contacts between participants and peer mentors that will be a mix of in-person, virtual, and texting. The intervention components and communication between adolescents and peer mentors with T1D will be guided by SDT, and designed to overcome the key psychosocial barriers to PA. The peer mentors that complete the training will deliver a 12-week intervention to increase behavioural skills that foster autonomy for goal setting and overcoming barriers to PA.
Study: NCT06321224

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breathing exercises
Description: Breathing exercises will be performed 3 days a week during 2 menstrual periods.

Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: No intervention will be made to the control group and they will be asked to continue their routine lives.
Study: NCT05631808

Intervention type: OTHER
Intervention: Epicardial adipose tissue volume and attenuation
Description: Epicardial adipose tissue volume and attenuation assessed by CT are the exposure factors in this study.

Intervention type: OTHER
Intervention: Epicardial adipose tissue volume and attenuation
Description: Epicardial adipose tissue volume and attenuation assessed by CT are the exposure factors in this study.

Intervention type: OTHER
Intervention: Epicardial adipose tissue volume and attenuation
Description: Epicardial adipose tissue volume and attenuation assessed by CT are the exposure factors in this study.
Study: NCT04225507

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Diet and exercise coaching
Description: All participants will receive diet and exercise goals and coaching.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet and exercise coaching
Description: All participants will receive diet and exercise goals and coaching.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CPAP Treatment
Description: CPAP treatment for sleep apnea and CPAP education and adherence coaching.
Study: NCT05224557

Intervention type: OTHER
Intervention: No intervention
Description: No intervention

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT04307550

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol
Description: 10 inhalations of an isopropyl alcohol pad

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 10 inhalations of a sterile saline pad
Study: NCT05508607

Intervention type: OTHER
Intervention: CDI-risk Classification Tool
Description: This tool will focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.
Study: NCT05200546

Intervention type: DIAGNOSTIC_TEST
Intervention: molecular assays to screen for eXDR
Description: VRE detection will be performed using VIASURE Vancomycin resistance Real Time PCR Detection Kit.~BD MAX Check-Points CPO will be used to detect carbapenemase-producing organisms.
Study: NCT05508841

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: tDCS and Cognitive Training
Description: Participants will receive mild stimulation or no stimulation along with cognitive training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tDCS and Cognitive Training
Description: Participants will receive mild stimulation or no stimulation along with cognitive training

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: tDCS and Cognitive Training
Description: Participants will receive mild stimulation or no stimulation along with cognitive training
Study: NCT05755776

Intervention type: DRUG
Intervention: TMF
Description: switch ETV to TMF
Study: NCT05323279

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: artificial intelligence assistance system
Description: The artificial intelligence assistance system can indicate abnormal lesions and real-time withdrawal speed and feedback the overspeed percentage.
Study: NCT05130385

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: High-resolution optical coherence tomography (High-Res-OCT)
Description: Imaging with high-resolution optical coherence tomography

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT
Study: NCT05379764

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Embodiment
Description: Embodiment of a real human in a virtual human (avatar) means that the real human feels incarnated in the avatar. This happens when the real human sees the VRscenario from first person perspective, that the real human can make the avatar move (=agency over the avatar), multi-sensorial integration (=there is a link between the brain of the real human and the avatar. Example, when the avatar sits on a chair, the real human will too and he feels that he is sitting on a chair. Or when the avatar is moving the real human is doing the same movement (and of course the brain of the real human is aware of this movement)) and co-location (= avatar and real human have the sane posture).

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Observation
Description: The person is looking at the VR scenario as if s/he was looking at a TV
Study: NCT06391970

Intervention type: DEVICE
Group type: OTHER
Intervention: Cognitive screening
Description: The cognitive abilities of participants will be assessed using two different interventions: the first utilizing the new digital device, and the second employing the gold standard method.
Study: NCT05130385

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT

Intervention type: DEVICE
Intervention: Standard spectral domain OCT (SD-OCT)
Description: Imaging with standard spectral domain OCT
Study: NCT04925219

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Remotely supervised exercise programme
Description: Electronic walking log Fortnightly video/telephone calls with physiotherapist

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-directed exercise
Description: Electronic walking log and instructions to exercise 4 times per week.
Study: NCT04535102

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polatuzumab Vedotin
Description: Polatuzumab vedotin is an ADC designed for the targeted delivery of MMAE(mono-methyl auristatin E), a potent microtubule inhibitor to lymphoma cells expressing CD79b. MMAE has a mechanism of action that is similar to that of vincristine.
Study: NCT06012084

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered Cystic Fibrosis Mental Health Prevention, Wellness, and Resource (iCF-PWR) program
Description: The iCF-PWR program is a self-guided mental health prevention program designed for families with CF.
Study: NCT05476380

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: camrelizumab
Description: Camrelizumab:200 mg, IV., d1, q3w; Paclitaxel:175 mg/m2,continuous IV., d1, 24h q3w; Cisplatin:75 mg/m2, iv., d1,q3w
Study: NCT05732493

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Serplulimab
Description: Serplulimab 300mg, d1, q3w

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: short-term radiotherapy
Description: radiation: 25Gy/5Fx

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: 130mg/m2 d1 q3w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 130mg/m2 d1 q3w

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: 1000mg/m2 d1-14 q3w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1000mg/m2 d1-14 q3w
Study: NCT05988684

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Patients randomized to metformin group will be instructed to take 500 mg metformin daily for 1 week before titrating up to twice a day
Study: NCT05876767

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR444336
Description: Single or repeated dose subcutaneous injection
Study: NCT06393413

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jiedu Yizhi Formula
Description: Observation after 24 weeks of drug treatment

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Donepezil Hydrochloride Tablets
Description: Donepezil Hydrochloride Tablets
Study: NCT06134115

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lipocet® (food supplement)
Description: 1 sachet, 10 ml corresponding to 1500 mg of Cetylated fatty acids
Study: NCT06052605

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Aging in People with Epilepsy Program
Description: This a 12-week group educational program providing education on healthy aging, chronic disease management, dementia, and modifiable lifestyle dementia risk factors.
Study: NCT06134115

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Lipocet Placebo
Description: Lipocet Placebo matching to Lipocet
Study: NCT05034042

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fezolinetant
Description: oral
Study: NCT06187285

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 MG
Description: Patient will get Empagliflozin 25

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sitagliptin 100mg
Description: Patient will get Sitagliptin 100 mg
Study: NCT05034042

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fezolinetant
Description: oral

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral
Study: NCT05059210

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Coach McLungs Intervention
Description: Practices have received implementation of Coach McLungs
Study: NCT05876767

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single or repeated dose subcutaneous injection
Study: NCT03792295

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: acetominophen, ibuprofen, oxycodone
Description: Multimodal pain treatment group

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone
Description: Classic opiod pain treatment group
Study: NCT06201429

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mechanical Tissue Resuscitation (MTR™)
Description: Mechanical Tissue Resuscitation (MTR™) to externally drain excess fluid volume from the site of surgery in patients who have undergone a surgical procedure (craniotomy/craniectomy) for which a portion of the skull has been removed resulting in exposure of the dura/brain and require drainage of fluid.
Study: NCT05637164

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: norepinephrine bitartrate
Description: The treatment group will receive a continuous infusion of norepinephrine at the beginning of anesthesia induction until 15 minutes after intubation. The dosage of norepinephrine was decided by the up-and-down sequential allocation method with an initial dose of 0.05 µg/kg/min and a 0.005 µg/kg/min gradient.
Study: NCT05973292

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: resin cement containing phosphate ester monomer 10-methacryloyloxydecyl dihydrogen phosphate
Description: Adhesive resin cement containing an MDP agent that is added to bonding agents to enhance bonding to ceramics like Ziconia and E-max
Study: NCT05306262

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hypnosis session
Description: Comfort hypnosis: accompaniment of a pleasant memory.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hypnosis session
Description: Comfort hypnosis: accompaniment of a pleasant memory.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Catalepsy
Description: Catalepsy of the hand.
Study: NCT04904744

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low tailored message
Description: 2 low tailored text or phone message reminders that child is overdue for well child check visit

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No message
Description: No reminders are sent

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low tailored message plus COVID-19 vaccine message
Description: 2 low tailored text or phone message reminders that child is overdue for well child check visit and that COVID-19 vaccine is available
Study: NCT06537765

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medical treatment
Description: All women with endometriosis in all groups (A, B, \& C) will receive their medical treatment as prescribed by the gynecologist.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medical treatment
Description: All women with endometriosis in all groups (A, B, \& C) will receive their medical treatment as prescribed by the gynecologist.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medical treatment
Description: All women with endometriosis in all groups (A, B, \& C) will receive their medical treatment as prescribed by the gynecologist.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound (US)
Description: Women will be asked to assume supine lying position, and the lower abdomen will be cleaned thoroughly with alcohol and dried well thereafter. Ultrasound gel will be distributed over the lower abdomen .The device will be adjusted to Frequency of 1MHz, Mode: continuous wave, Intensity: 1.5W/cm, duration of treatment: 15 minutes for the treatment site, then the skin will be cleaned again to remove ultrasound gel.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound (US)
Description: Women will be asked to assume supine lying position, and the lower abdomen will be cleaned thoroughly with alcohol and dried well thereafter. Ultrasound gel will be distributed over the lower abdomen .The device will be adjusted to Frequency of 1MHz, Mode: continuous wave, Intensity: 1.5W/cm, duration of treatment: 15 minutes for the treatment site, then the skin will be cleaned again to remove ultrasound gel.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Description: TENS electrodes will be placed on specific acupuncture points for women in supine position. These points include VB29, ST36, CV6, CV4, LV3, KD3, SP6, and SP9. The treatment aims to improve blood circulation, remove adhesions, regulate menstrual activity and hormones, and prevent new adhesions and menstrual reflux in endometriosis patients.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Description: TENS electrodes will be placed on specific acupuncture points for women in supine position. These points include VB29, ST36, CV6, CV4, LV3, KD3, SP6, and SP9. The treatment aims to improve blood circulation, remove adhesions, regulate menstrual activity and hormones, and prevent new adhesions and menstrual reflux in endometriosis patients.
Study: NCT06637488

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cleft lip repair using fisher technique
Description: Disinfection of the field using Betadine , marking for the incision lines on the lip and vermilion on skin and mucosa , doing incisions as described by Fisher sub anatomic unit repair in 2005 , suturing using vicryl and prolene sutures. suturing the nasal conformer in the cleft side

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cleft lip repair using fisher technique
Description: Disinfection of the field using Betadine , marking for the incision lines on the lip and vermilion on skin and mucosa , doing incisions as described by Fisher sub anatomic unit repair in 2005 , suturing using vicryl and prolene sutures. No nasal conformers used in this group
Study: NCT04884477

Intervention type: BIOLOGICAL
Intervention: Convalescent Plasma
Description: Convalescent Plasma
Study: NCT05272020

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: CPET, 6MWT, QOL assessment
Description: Preoperative and postoperative (6 months + 18 months) assessment

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: CPET, 6MWT, QOL assessment
Description: Preoperative and postoperative (6 months + 18 months) assessment
Study: NCT05634694

Intervention type: OTHER
Intervention: No interventions.
Description: No interventions.
Study: NCT05642065

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hip muscle activation home exercise program
Description: Participants will perform a home exercise program consisting of five hip muscle activation exercises with the use of a resistance band. The program will be eight weeks in duration, and participants will perform the exercises twice weekly.
Study: NCT06347692

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: antigravity treadmill
Description: An Alter G treadmill (Alter G Pro 200, Alter G Inc, USA) was used to provide training to the patients in the antigravity treadmill group. The Alter G allows the patient to change their body weight from 20% to 100% in 1% increments. The air pressure inside the lower body positive pressure chamber can be adjusted from 0 to 2.0 kilopascal above atmospheric pressure. They are very comfortable to train in for long periods of time and have simple controls for adjusting body weight, speed, and inclination.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physical therapy exercise program
Description: Both groups received the same traditional physical therapy program for 12 weeks, three times a week, for 30 min each. The conventional physical therapy treatment consisted of acupuncture transcutaneous electrical nerve stimulation, Hot moist pack, Ultrasound and quadriceps setting